Live, In-person Symposium - Friday-Saturday, March 6-7, 2026
JW Marriott Miami, Miami, FL
Given the increasing frequency of hematologic malignancies and the complexities of treatments with novel agents, particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision-making and management, therefore, have become more complex.
This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma by novel immunotherapies, stem cell transplantation and treatment combinations. Updates on evolving immunologically and molecular-based system therapies will be profiled and discussed.
Upon completion of this symposium, participants should be better able to:
- Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies.
- Provide an update of new molecular and immunological treatments being developed for these diseases.
- Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
- Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.
